L, S., T, L., Y, L., S, L., X, H., J, Z., & Y, C. (2025). In vivo development of elevated linezolid resistance mediated by a deletion in ribosomal protein L3 in clinical Enterococcus faecium. Antimicrobial agents and chemotherapy, 69(12), e0087125. https://doi.org/10.1128/aac.00871-25
Παραπομπή σε μορφή Chicago (17η εκδ.)L, Sun, Lei T, Liu Y, Lu S, Hua X, Zhang J, και Chen Y. "In Vivo Development of Elevated Linezolid Resistance Mediated by a Deletion in Ribosomal Protein L3 in Clinical Enterococcus Faecium." Antimicrobial Agents and Chemotherapy 69, no. 12 (2025): e0087125. https://doi.org/10.1128/aac.00871-25.
Παραπομπή σε μορφή MLA (9th εκδ.)L, Sun, et al. "In Vivo Development of Elevated Linezolid Resistance Mediated by a Deletion in Ribosomal Protein L3 in Clinical Enterococcus Faecium." Antimicrobial Agents and Chemotherapy, vol. 69, no. 12, 2025, p. e0087125, https://doi.org/10.1128/aac.00871-25.